Lepu Medical Technology (Beijing) Co., Ltd. (referred to as Lepu Medical Group) was founded in 1999. Through adhering to the road of technological innovation, quality leadership and win-win cooperation, Lepu Medical Group is striving to establish China's leading four-in-one cardiovascular industry chain platform company including equipment, pharmaceutical, medical services and mobile medical. We allow more patients to get the benefits from advanced medical technology progress in a timely, effective and safe manner.

PW Medtech  Group Co., Ltd. is a  medical device company in China, focusing on the high growth and high profit margins of the Chinese medical device market. The main business includes the research and development, manufacturing and sales of high-end infusion device products. In addition to focusing on endogenous growth from its main business, the Group is also committed to fully leveraging the synergies between R&D, distribution network and business operations by the development strategy of mergers and acquisitions and advantageous integration. It aims to build the Group into a comprehensive platform of high value consumable for China’s medical devices.

Beijing Fert Technology Co., Ltd. takes the cutting-edge nuclear physics technology as the independent intellectual property right, and relies on the core technology--core nuclear pore membrane separation technology to transform the nuclear track technology achievements into the medical device field. It is a high-tech enterprise specializing in research, development and production of high precision of medical precision filters, precision filtration infusion device series products and medical device products. The main products are GLQ series precision filters, SYQ series precision filtration infusion devices. It creates a new industry of precision filtration infusion sets and establishes a new concept of clinical safe infusion.

Lepu (Beijing) Diagnostic Technology Co., Ltd. is a wholly-owned subsidiary of Lepu Technology. In October 2015, the New OTC Market was officially listed. It has 82 in-vitro biochemical diagnostic reagent registration certificates and a number of invention patents and copyrights. It has all kinds of products, wide coverage, perfect after-sales service system. It is a high-tech enterprise in the research, development, production and sales of in vitro biochemical diagnostic reagents.

Beijing Jianan Biotechnology Co., Ltd. is a high-tech enterprise engaged in research and production of in vitro diagnostic reagents. In 2012 and 2013, it has developed kits for forming hepatitis and eugenics series, and has obtained the corresponding registration number with a total number of 15 items. At present, the company devotes to the development of chemiluminescence platform products, and has successfully developed such projects as cardiac markers, tumors, and preoperative eight items and etc., all of which are in the process of registration.

Beijing Taijie Weiye Technology Co., Ltd. was founded in 2008. It is a high-tech Sino-foreign joint venture that integrates research, development, production, sales and service of medical devices such as neurological interventional and biological rapid diagnostic reagents (POCT). The main products include intravascular catheters, embolization equipment, implantable equipment, stents, in vitro diagnostic reagents, clinical analysis instruments. Some products have passed CFDA registration and CE certification.